Ocugen prices $22.5M common stock offering at $1.50/share; led by RTW Investments

Ocugen, Inc.

Priced 15M shares of common stock at $1.50/share for gross proceeds of $22.5M; net proceeds ~$20.8M.
Offering led by RTW Investments with participation from new and existing investors; expected to close Jan 22, 2026.
Proceeds to be used for general corporate purposes, capital expenditures, working capital, and G&A.
Oppenheimer & Co. acting as sole book-running manager for the offering.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

Ocugen, Inc. entered into Underwriting Agreement with Oppenheimer & Co. Inc. valued at 15,000,000 shares of common stock at $1.50 per share, net proceeds approximately $20.8 million (effective 2026-01-20).

Action: entry
Agreement: underwriting
Counterparty: Oppenheimer & Co. Inc.
Value: 15,000,000 shares of common stock at $1.50 per share, net proceeds approximately $20.8 million
Effective: 2026-01-20

Exact text from the filing

On January 20, 2026, Ocugen, Inc. (the “ Company ”) entered into an underwriting agreement (the “ Underwriting Agreement ”) with Oppenheimer & Co. Inc. (the “ Underwriter ”), pursuant to which the Company agreed to issue and sell to the Underwriter, in an offering (the “ Offering ”) 15,000,000 shares of the Company’s common stock, par value $0.01 per share (the “ Common Stock ”), at an offering price of $1.50 per share (the “ Offering Price ”).

View on SEC.gov

284 material agreements filed in the last 30 days. Browse all material agreements →

Ocugen, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-26-005454

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.